PubMed Health⌕ Search

PubMed · 3279611

The second histocompatibility locus in humans.

Abstract

Even when HLA is completely matched in sibling donor transplants, as many as one third of the transplants are lost in 10 years. This means that a second or third histocompatibility locus plays some role in rejection of kidney grafts. We postulate that the second locus is Lewis. First, because among 18 second cadaver donor transplant patients having Lewis antibodies, the 1-year graft survival rate was 32% compared to 61% in 37 patients without Lewis antibodies (P = .02). The Lewis antibodies presumably were produced in the course of rejection of the first graft and had an effect on the success of the second graft. As indirect evidence, Lewis mismatching would be expected to occur more frequently in black patients than white, and correspondingly, a lower graft survival rate was noted in black patients receiving sibling, parent, and cadaver donor grafts.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P I Terasaki, D Chia, M R Mickey. 1988. The second histocompatibility locus in humans.. https://pubmed.ncbi.nlm.nih.gov/3279611/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Composite tissue allograft extends a helping hand to transplant immunologists.

The first successful human hand transplantation, performed on September 1998, has translated the scope of 'composite tissue allotransplantation' from research concepts into clinical practice. Beyond microsurgical problems that have been overcome several years ago, the main obstacle that still prevents the generalization of composite tissue allotransplantation is immunologic. This review, which summarizes the evidence obtained both from experimental animal models and from the first recipients of a hand transplant, is focused on the two immunological characteristics of composite allografts that set them apart from other solid organ allografts: (i) they contain skin tissue that elicits a strong immune response; and (ii) they contain lymphoid tissues (such as bone marrow and lymph nodes) that have the potential both to attack the recipient, and also to down-modulate the host immune response and induce tolerance. While on one hand, the composite tissue allografts raise new challenges to transplant immunologists, on the other they provide answers to questions that have remained unresolved for a long time. In this sense, composite tissue allografts extend a helping hand to transplant immunologists.

Graft Survival↗